Comprehensive efficacy of anti interleukin-4 receptor alpha antibody in patients with severe asthma

Comprehensive efficacy of anti interleukin-4 receptor alpha antibody in patients with severe asthma - efficacy of anti interleukin-4 receptor alpha antibody in severe asthma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000038669

Enrollment

Registered

2019-11-25

Start date

2019-09-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with asthma. patients whose asthma has not been well controlled despite high doses of inhaled cotricosteroid and maintenance treatment. patients who consent to the study.

Exclusion criteria

Exclusion criteria: patients who have other respiratory diseases. patients who have a history of smoking more than 10 pack-year. patients who are pregnant or nurse.

Design outcomes

Primary

Measure	Time frame
cough and sputum related questionnaire score biomarker of induced sputum	—

Countries

Japan

Contacts

Public ContactTomoko Tajiri

Nagoya City University Respiratory Medicine, Allergy and Clinical Immunology

tomokot@med.nagoya-cu.ac.jp052-853-8216

Outcome results